PF4 and Hermansky-Pudlak syndrome: Furthermore, while clotting appeared macroscopically intact in all HPS samples obtained from subjects using OA (Figure 2), PF-4 levels in these samples were significantly lower than those in HPS obtained from subjects not using OA (Figure 3), suggesting a possible interference of OA administration with platelet activation in situ, and factor release.